Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (10785)	6/27/2000 10:30:00 AM
From: jeffbas	Read Replies (1) \| Respond to of 78530

Armin, I basically know nothing about SOFN. I was just trying to make the point that valuations of 20-50 times sales of this era, when they should be 20-50 times earnings, are not likely to be prevalent at some future point in time, in my opinion. The company is not much more than a development stage company it appears, similar to many biotechs. Valuation of this kind of company often depends on the whim of the market, not on sales (and earnings) you can see. Good luck. I hope you don't need it.